El-Etr S H, Cirillo J D
Dept. of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, 203 VBS, Fair and East Campus Loop, Lincoln, NE 68583, USA.
Front Biosci. 2001 Jun 1;6:D737-47. doi: 10.2741/sahar.
Since many mycobacteria are facultative intracellular pathogens, their ability to cause disease involves entry, survival and replication within host cells. Despite the fact that mycobacteria were first associated with disease more than 125 years ago, the first step in the production of an infection, entry into host cells, is not well understood. Mycobacteria have the ability to enter a number of different cell types, but the primary cell type that they are thought to replicate within during human disease is macrophages. Since macrophages have a large number of receptors that are designed for relatively non-specific uptake of foreign particles, there are multiple routes by which nearly any bacteria can be taken up. The outcome of mycobacterial entry into macrophages via different mechanisms is unclear. Although it is thought that mycobacteria may enter macrophages by a mechanism that allows them to avoid lysosomal fusion, it remains possible that mycobacteria enter by more than one mechanism, yet remain viable and replicate intracellularly through modification of the phagosome. In the current discussion we will review mycobacterial research specifically relating to the mechanisms of entry into host cells. Although much progress has been made in our understanding of entry by mycobacteria, we anticipate that clarification of the role of entry in pathogenesis will require further application of newly developed molecular tools to dissect each of the proposed mechanisms.
由于许多分枝杆菌是兼性细胞内病原体,它们引发疾病的能力涉及在宿主细胞内的进入、存活和复制。尽管分枝杆菌在125多年前就首次被发现与疾病有关,但感染产生的第一步,即进入宿主细胞,目前仍未完全了解。分枝杆菌能够进入多种不同类型的细胞,但在人类疾病中,它们被认为主要在巨噬细胞内复制。由于巨噬细胞有大量用于相对非特异性摄取外来颗粒的受体,几乎任何细菌都有多种途径被摄取。分枝杆菌通过不同机制进入巨噬细胞的结果尚不清楚。虽然人们认为分枝杆菌可能通过一种使其避免与溶酶体融合的机制进入巨噬细胞,但分枝杆菌也有可能通过多种机制进入,并且通过对吞噬体的修饰在细胞内保持存活并进行复制。在当前的讨论中,我们将回顾与分枝杆菌进入宿主细胞机制相关的研究。尽管我们对分枝杆菌进入机制的理解已经取得了很大进展,但我们预计,要阐明进入在发病机制中的作用,需要进一步应用新开发的分子工具来剖析每种提出的机制。